The Los Angeles Post
U.S. World Business Lifestyle
Today: March 19, 2025
Today: March 19, 2025
Maggie Fick

Maggie Fick

Staff Writer

Latest From Maggie Fick

Health|MidEast|World

Main maternity hospital in Rafah stops admitting patients

The main maternity hospital in the Gaza Strip's crowded southern city of Rafah has stopped admitting patients, the United Nations Population Fund (UNFPA) said on

Main maternity hospital in Rafah stops admitting patients
Business|Finance|Stock Markets

AstraZeneca aims for $80 billion in total revenue by 2030

AstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by the expected launch of 20 new medicines and through

AstraZeneca aims for $80 billion in total revenue by 2030
Health|Science

Wegovy users have less kidney-related health problems, analysis of Novo study finds

Novo Nordisk's Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the

Wegovy users have less kidney-related health problems, analysis of Novo study finds
Business|Finance|Health|US

GSK shares slide after US health agency narrows scope of RSV shots

GSK shares fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed its age recommendation for use of respiratory syncytial virus

GSK shares slide after US health agency narrows scope of RSV shots
World

Gaza's child amputees face further risks without expert care

Eleven-year-old Noor's left leg was almost entirely torn off when her home in Jabalia, Gaza was hit by an explosion in

Gaza's child amputees face further risks without expert care
MidEast|News|World

How many Palestinians have died in Gaza war and how will the counting continue?

Israeli forces unleashed an aerial and ground blitz against Hamas in Gaza after a cross-border rampage by the enclave's ruling

How many Palestinians have died in Gaza war and how will the counting continue?
MidEast|News|World

Displaced Gazans cram into Rafah despite fears of attack

Tens of thousands of displaced Palestinians have crammed into the Rafah area on Gaza's border with Egypt to escape Israeli bombardments,

Displaced Gazans cram into Rafah despite fears of attack
News|World

Despite Gaza death toll soaring, U.S. unlikely to rethink weapons supplies to Israel

Facing a soaring death toll from Israel's renewed offensive in southern Gaza, the Biden administration is trying to

Despite Gaza death toll soaring, U.S. unlikely to rethink weapons supplies to Israel
Business|Health|Science

Eli Lilly: still seeking UK approval on pen for weight-loss drug

Eli Lilly on Thursday said it has not yet gained approval in Britain for the injection pen it plans to use for its Mounjaro drug against obesity and

Eli Lilly: still seeking UK approval on pen for weight-loss drug
Business|Europe|Health

Weight-loss drugs in spotlight as pharma services firms rush to snap up business

Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for

Weight-loss drugs in spotlight as pharma services firms rush to snap up business
Business|Health

Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing

Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular

Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing
Business|Health|Science|Technology

GSK buys COVID, influenza vaccines from retrenching CureVac

British drugmaker GSK on Wednesday bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA credentials and extending the

GSK buys COVID, influenza vaccines from retrenching CureVac
Health|Science

Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows

Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking

Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows
News|US

Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market

Democratic U.S.

Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market
Africa|Health|Science|World

Second malaria vaccine launched in Ivory Coast in new milestone

The world's second vaccine against malaria was launched on Monday as Ivory Coast began a routine vaccine programme using shots developed by the University of Oxford

Second malaria vaccine launched in Ivory Coast in new milestone
Business|Finance

Novo owner backs Swiss biotech Asceneuron in $100 million round

Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder of Wegovy maker Novo Nordisk to fund

Novo owner backs Swiss biotech Asceneuron in $100 million round
Business|Finance|Health|Stock Markets

AstraZeneca raises profit outlook on strong medicines demand

Anglo-Swedish drugmaker AstraZeneca raised its full year sales and profit forecast on Thursday after beating analyst expectations for second-quarter

AstraZeneca raises profit outlook on strong medicines demand
Business|Health|News|Science|US

Lilly, Novo Nordisk battle for weight-loss market lands at the pharmacy shelf

As Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding

Lilly, Novo Nordisk battle for weight-loss market lands at the pharmacy shelf
Business|Finance|Health

Novo Nordisk posts rare miss on sales of obesity drug Wegovy

Novo Nordisk on Wednesday trimmed its full-year profit outlook after reporting weaker-than-expected quarterly sales of its popular weight-loss drug Wegovy, stirring

Novo Nordisk posts rare miss on sales of obesity drug Wegovy
Health

New Alzheimer's drug deemed too costly for UK's state-run health service

Alzheimer's patients in Britain's state-run health service are unlikely to get access to Eisai and Biogen's new Leqembi drug, after it was approved on Thursday by the

New Alzheimer's drug deemed too costly for UK's state-run health service
Business|Europe|Finance|Health|Stock Markets

Novo Nordisk shares drop nearly 5% on disappointing obesity pill data

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental

Novo Nordisk shares drop nearly 5% on disappointing obesity pill data
Business|Economy|Finance|US

Consumer groups ask FTC to block Novo Holdings-Catalent deal

U.S. consumer groups and two large labor unions urged the U.S.

Consumer groups ask FTC to block Novo Holdings-Catalent deal
Business|Finance|Health

GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and

GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand
Business|Europe|Finance|Stock Markets

EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6

EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent, according

EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6
Business|Finance|Health|Stock Markets

Novo Nordisk's Wegovy weight-loss drug sales beat forecast, shares jump

Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring investors

Novo Nordisk's Wegovy weight-loss drug sales beat forecast, shares jump

Follow